Figure 2From: PIK3CAmutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroupsSubgroup analysis survival curves. (a) Metastasis-free survival curves of progesterone receptor-positive (PR+) patients with PIK3CA wild-type and -mutated tumors. (b) Metastasis-free survival curves of ERBB2+ patients with PIK3CA wild-type and -mutated tumors. PIK3CA, phosphatidylinositol 3-kinase, catalytic, alpha polypeptide gene.Back to article page